Innoviva (NASDAQ: INVA) reported Q2 EPS of ($0.55), $0.79 worse than the analyst estimate of $0.24. Revenue for the quarter came in at $99.9 million versus the consensus estimate of $76.28 million.

For earnings history and earnings-related data on Innoviva (INVA) click here.